9DC Stock Overview
Engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.45 |
| 52 Week High | JP¥9.55 |
| 52 Week Low | JP¥6.75 |
| Beta | 0.45 |
| 1 Month Change | 3.68% |
| 3 Month Change | 6.96% |
| 1 Year Change | -5.59% |
| 3 Year Change | 34.13% |
| 5 Year Change | -1.74% |
| Change since IPO | -26.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DC | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 4.3% | 2.2% | 2.3% |
| 1Y | -5.6% | 2.6% | 11.9% |
Return vs Industry: 9DC underperformed the German Chemicals industry which returned 2.6% over the past year.
Return vs Market: 9DC underperformed the German Market which returned 11.9% over the past year.
Price Volatility
| 9DC volatility | |
|---|---|
| 9DC Average Weekly Movement | 3.6% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9DC has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9DC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,134 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| 9DC fundamental statistics | |
|---|---|
| Market cap | €2.26b |
| Earnings (TTM) | €357.75m |
| Revenue (TTM) | €3.55b |
6.3x
P/E Ratio0.6x
P/S RatioIs 9DC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DC income statement (TTM) | |
|---|---|
| Revenue | JP¥576.74b |
| Cost of Revenue | JP¥408.39b |
| Gross Profit | JP¥168.35b |
| Other Expenses | JP¥110.21b |
| Earnings | JP¥58.14b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
| Earnings per share (EPS) | 215.19 |
| Gross Margin | 29.19% |
| Net Profit Margin | 10.08% |
| Debt/Equity Ratio | 71.9% |
How did 9DC perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield26%
Payout RatioDoes 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks| Daicel dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 24 2025 |
| Days until Ex dividend | 63 days |
| Days until Dividend pay date | 151 days |
Does 9DC pay a reliable dividends?
See 9DC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/23 03:25 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Daicel Corporation is covered by 21 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Sze Tee | CGS International |